- EUR/USD’s daily upside clinches peaks near 1.2070.
- The greenback tumbles further and breaches the 91.00 level.
- German 10-year Bund yields climb to highs near -0.22%.
The buying pressure around the European currency picks up further pace and lifts EUR/USD to new 3-day highs around 1.2070.
EUR/USD bid on USD weakness
EUR/USD manages to return to the positive territory following two consecutive daily pullbacks, regaining around a cent since weekly lows in the 1.1990/85 band (Wednesday).
The renewed bullish momentum in the pair comes exclusively in response to the increasing selling pressure hitting the buck, particularly after somewhat disappointing data from the ADP report on Wednesday and dovish comments from FOMC members, who talked down any chances of tapering (for the time being) and reiterating the idea that upticks in inflation should be temporary.
Earlier in the euro calendar, Retail Sales in the bloc expanded at a monthly 2.7% in March and 12% from a year earlier. In the US, Initial Claims rose by 498K from a week earlier, advanced Nonfarm Productivity is expected to expand 5.4% QoQ in Q1 and Unit Labor Costs are seen contracting 0.3% QoQ during the same period.
What to look for around EUR
EUR/USD rebounds from the 1.1985/80 band and looks to reclaim the area north of the psychological 1.20 yardstick. Despite the ongoing corrective downside in the pair, the outlook for the single currency stays constructive on the back of the investors’ shift to the improved growth outlook in the Old Continent now that the vaccine campaign appears to have gained some serious pace and solid results from key fundamentals pari passu with the surging morale in the bloc.
Key events in the euro area this week: ECB’s Lagarde speech (Friday).
Eminent issues on the back boiler: Asymmetric economic recovery in the region. Sustainability of the pick-up in inflation figures. Progress of the vaccine rollout. Probable political effervescence around the EU Recovery Fund. German elections.
EUR/USD levels to watch
So far, spot is gaining 0.48% at 1.2061 and faces the next up barrier at 1.2150 (monthly high Apr.29) followed by 1.2243 (monthly high Feb.25) and finally 1.2349 (2021 high Jan.6). On the other hand, a breach of 1.1985 (monthly low May 5) would target 1.1942 (200-day SMA) en route to 1.1887 (61.8% Fibo of the November-January rally).
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.